Stock ANEB ANEBULO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Anebulo Pharmaceuticals, Inc.

Equities

ANEB

US0345691036

Delayed Nasdaq
Other stock markets
 15:05:45 02/05/2024 BST 		5-day change 1st Jan Change
3.2 USD +8.11% Intraday chart for Anebulo Pharmaceuticals, Inc. +14.51% +32.23%
02-13 Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Starts Anebulo Pharmaceuticals at Buy With $6 Price Target
MT
HC Wainwright Initiates Anebulo Pharmaceuticals With Buy Rating, Price Target is $6
MT
Benchmark Adjusts Anebulo Pharmaceuticals' Price Target to $8 From $10, Keeps Speculative Buy Rating
MT
Ladenburg Thalmann Initiates Anebulo Pharmaceuticals at Buy with $6 Price Target
MT
Benchmark Adjusts Price Target on Anebulo Pharmaceuticals to $10 From $15, Keeps Speculative Buy Rating
MT
ANEBULO PHARMACEUTICALS : Benchmark Initiates Anebulo Pharmaceuticals at Buy Rating With $15 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANEB Stock
  4. News Anebulo Pharmaceuticals, Inc.
  5. Analyst Reco.